{"database":"biostudies-other","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"submitter":["Jeroen Pennings"],"funding":["Horizon Europe Research and Innovation Programme","European Union’s Horizon 2020 Research and Innovation Programme"],"species":["Homo sapiens (human)"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-BSST2267"],"repository":["biostudies-other"],"funding_grant_id":["101057014","964537"],"pubmed_authors":["Jeroen Pennings"],"additional_accession":[]},"is_claimable":false,"name":"Cell viability in HepG2 cells after compound exposure - CellTiter assay","description":"We quantified cell viability in HepG2 cells after 24 h of compound exposure. This was done using four exposure scenarios: (1) HepG2 cells receiving acute exposure; (2) maturated HepG2 cells receiving acute exposure; (3) maturated HepG2 cells receiving repeated exposure; (4) maturated HepG2 cells receiving repeated exposure and recovery. Viability was measured using the CellTiter-Fluor Cell Viability Assay, which is a nonlytic, single-reagent-addition fluorescence assay that measures the relative number of live cells in a culture population after experimental manipulation. \nThis study was performed as part of the RISK-HUNT3R project and the PARC project.","dates":{"release":"2026-04-30T00:00:00Z","modification":"2026-04-30T01:01:46.338Z","creation":"2025-11-07T14:12:50.518Z"},"accession":"S-BSST2267","cross_references":{}}